Skip to content
Search

Latest Stories

Racism 'a root cause' of Covid-19 exposure risk among BAME people, says report

RACIAL discrimination is a major cause of high Covid-19 death rates among black, Asian and minority ethnic communities in the UK, an official inquiry has found.

The revelation came as the media accessed a section of the Public Health England‘s recent review that had been withheld, allegedly due to concerns that the findings could fuel the ongoing anti-racism flare-up.


“Stakeholders pointed to racism and discrimination experienced by communities and more specifically BAME key workers as a root cause to exposure risk and disease progression,” said the document obtained by Sky News.

“It is clear from discussions with stakeholders the pandemic exposed and exacerbated longstanding inequalities affecting BAME communities in the UK.”

Reports also noted that the unpublished section of the review had stressed on giving targeted health advice in the event of a second wave of the coronavirus outbreak.

Critics and the opposition led by Labour slammed the government on withholding crucial parts of the PHE report, which had said BAME people were up to 50 per cent more likely to die of Covid-19.

Jonathan Ashworth, the shadow health secretary, said: “The impact of Covid-19 on people from BAME communities is serious, and as the data shows for many it can be fatal. This should demand urgent action from ministers. Instead we have had misleading statements and a lack of transparency.

“We shouldn’t have to reply on leaks. The report should be published in full as soon as possible and action taken.

“Labour have been raising concerns for weeks and calling for greater use of targeted testing and protection for staff on the frontline, for example.”

Last week, the British Medical Association urged the government to explain on why it did not publish “the full report” on the pandemic’s disproportionate impact on BAME communities.

The government was accused of a “scandal” after a British-Indian academic, who had peer-reviewed the PHE inquiry paper on tackling the higher Covid-19 risks faced by BAME communities, revealed that the recommendations laid out had not been published.

“Without recommendations there can be no actions,” said Raj Bhopal, emeritus professor of Public Health at the Usher Institute, College of Medicine and Veterinary Medicine, at the University of Edinburgh.

He said the recommendations file should me immediately published, and “those who have denied its existence must apologise to the public”.

The Parliament, Bhopal alleged, had “not been told the full truth”.

He said the document — with “every hallmark of a [government] report ready to go to the press” — had recommendations and evidence from about 4,000 people and organisations.

In a letter to Health Secretary Matt Hancock, BMA chair Dr Chaand Nagpaul said: “I’m finding it inexplicable the government did not release the full report at a time not only when the BAME community suffered so disproportionately with the virus, but also at a time when there was global outcry and outrage to racial inequalities.

“We feel [the review] hasn’t done justice to the aims of having an investigation and it has not done justice to the BAME community.

The letter sought a “clear response” on “why these pages and important recommendations were omitted from publication, especially when it is so critical that action is taken to save lives now and reduce race inequalities”.

The PHE had maintained that it planned to publish further details of the review this week.

"The government commissioned PHE to conduct an epidemiological review to analyse how different factors can impact on people’s health outcomes from Covid 19. This was published in full on the 2 June," it said.

"In parallel, Prof Kevin Fenton, on PHE’s behalf, engaged with a significant number of individuals and organisations within the BAME community, to hear their views, concerns and ideas about the impact of Covid-19 on their communities.

"This important engagement work will inform the work the equalities minister is now taking forward. We intend to both formally submit this work to the minister next week, and will publish it at the same time."

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less